DTC Advertising For ADHD, Acne, Antidepressant Meds Could Shift After FDA Study
This article was originally published in The Pink Sheet Daily
Seeking to better understand how adolescents process information in direct-to-consumer ads, agency proposes survey using web-based promotions for fictitious treatments.
You may also be interested in...
Flurry of new studies brings tally of FDA research projects on Rx drug promotion to 43; the 14 in progress and 7 pending peer review or recently published have a total cost of $15.5m.
FDA to assess whether claims such as '#1 prescribed' affect consumer views of drug product; project to cost $529,742. Chart notes price tag for 18 other DTC studies.
FDA plans to study whether frequent viewing of a TV ad effects viewer perception of risks and benefits; costing $1.2 million, it is the sixth DTC ad study to be announced this year.